The cannabis market is buzzing with potential, thanks to some big changes on the horizon. Investors are feeling hopeful, especially with President Trump showing interest in cannabis and hemp products. This could mean new rules and better opportunities for the industry.

One company, Verano Holdings, recently shared its earnings. They made $203 million, which is a bit more than last quarter but less than last year. They also had a net loss of $44 million due to some legal issues and facility problems. Other big names in the cannabis world, like Curaleaf and Trulieve, are about to report their earnings soon.

The cannabis industry has been up and down, but some leaders are optimistic. The CEO of Tilray Brands, Irwin Simon, thinks this could be a turning point. He believes new rules could attract more businesses to the U. S. market.

There are three main things driving this growth: Trump's interest in Medicare covering CBD, his talk about changing marijuana's drug status, and Congress working on hemp regulations. Cannabis is also becoming more popular than ever. In fact, daily marijuana use has surpassed daily drinking in the U. S. , according to a recent report.

The value of U. S. cannabis production grew by 40% last year, and the global market for cannabis-derived products is expected to hit $160 billion by 2032. This is big news for the industry.

In September, Trump shared a video on Truth Social about Medicare covering CBD. This video, made by a group advocating for seniors using cannabis, sparked a lot of interest. Cannabis stocks saw a big jump the day the video was posted. Some people think Trump is trying to gauge public opinion on cannabis products.

However, not everyone is convinced. Some experts say it's too early to tell if this is a full endorsement of cannabis reform. The FDA has only approved one CBD-based drug, and there's still a lot we don't know about CBD's effects.

Trump's post also adds to the momentum around regulating hemp. Congress is working on updates to the Farm Bill, which could set new standards for hemp-derived products. Clear regulations could help the industry grow sustainably and ensure consumer safety.

There's also talk about reclassifying marijuana. Trump mentioned that his administration is looking into changing marijuana's status from a Schedule I to a Schedule III drug. This could make it easier to sell and improve access to banking and financial services. It could also help with scientific research, which has been limited under the current classification.

Despite the optimism, there are still challenges. Some Republican lawmakers are pushing for stricter regulations on hemp-derived products, citing safety concerns. The market has rebounded but remains unregulated, which can be risky for consumers and investors.

Looking ahead, the future of the cannabis industry depends on what Trump and Congress do next. Clear regulations could shake up the industry and attract more investors. For many, it's not a question of when but what the regulations will be and how they'll be enforced.

TRUMP EFFECT

Cannabis Industry: Hope on the Horizon?

Continue reading...